Meeting
2021 ASCO Annual Meeting
Surveillance after complete response in patients with metastatic non-seminomatous germ-cell tumor (NSGCT).
Authors
Jennifer King
Indiana University School of Medicine, Indianapolis, IN
Jennifer King , Sandra K. Althouse , Clint Cary , Timothy A. Masterson , Richard Foster , Ryan Ashkar , Nasser H. Hanna , Lawrence H. Einhorn , Nabil Adra
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5018)
DOI
10.1200/JCO.2021.39.15_suppl.5018
Abstract #
5018
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma.
First Author: Andrea Pretta
Poster
2023 ASCO Annual Meeting
Avelumab as second-line or later (2L+) treatment in patients (pts) with metastatic Merkel cell carcinoma (mMCC): Analysis of real-world outcomes in France using the CARADERM registry and the French national healthcare database.
First Author: Astrid Blom Fily
Poster
2023 ASCO Annual Meeting
ABC-12: Exploring the microbiome in patients (pts) with advanced biliary tract cancer (BTC) in a first-line study of durvalumab in combination with cisplatin/gemcitabine (cis/gem).
First Author: Mairead Geraldine McNamara
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy.
First Author: Darren Cowzer